The enzymes acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are primary targets in attenuating the symptoms of neurodegenerative diseases. Their inhibition results in elevated concentrations of the neurotransmitter acetylcholine which supports communication among nerve cells. It was previously shown for trans-4/5-arylethenyloxazole compounds to have moderate AChE and BChE inhibitory properties. A preliminary docking study showed that elongating oxazole molecules and adding a new NH group could make them more prone to bind to the active site of both enzymes. Therefore, new trans-amino-4-/5-arylethenyl-oxazoles were designed and synthesised by the Buchwald-Hartwig amination of a previously synthesised trans-chloro-arylethenyloxazole derivative. Additionally, naphthoxazole benzylamine photoproducts were obtained by efficient photochemical electrocyclization reaction. Novel compounds were tested as inhibitors of both AChE and BChE. All of the compounds exhibited binding preference for BChE over AChE, especially for trans-amino-4-/5-arylethenyl-oxazole derivatives which inhibited BChE potently (IC 50 in mM range) and AChE poorly (IC 50 )100 mM). Therefore, due to the selectivity of all of the tested compounds for binding to BChE, these compounds could be applied for further development of cholinesterase selective inhibitors.
Introduction
Acetylcholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase (BChE, EC 3.1.1.8) are two related enzymes present in vertebrates and plants. In humans, these enzymes are products of different genes but share about 54% of their amino acid sequence 1 . The major difference in their active site are the 14 aromatic amino acid residues in AChE which correspond to 8 aromatic and 6 aliphatic residues in BChE 2 . This enables BChE to hydrolyse larger substrates and ligands than AChE and is accountable for the binding selectivity of cholinesterases [3] [4] [5] [6] .
AChE has an essential physiological role in the body as it controls the transmission of nerve impulses in the cholinergic synapses of the central and peripheral nervous system by hydrolysis of the neurotransmitter acetylcholine. It also has a role in neuritogenesis, cell adhesion, proliferation and cell interactions, synaptogenesis, dopamine neuronal activation, the formation of amyloid fibres characteristic for Alzheimer's disease, haematopoiesis and thrombopoiesis [7] [8] [9] . The role of BChE is not physiologically essential but it could be assigned to the detoxification of xenobiotics (organophosphates and carbamate pesticides, cocaine, aspirin, succinyldicholine, etc.) and bioactivation of drugs (bambuterol, heroin, etc.) 10, 11 . Also, BChE serves as a co-regulator of cholinergic neurotransmission and is capable of catalysing the hydrolysis of acetylcholine 12 . It was found that high BChE levels are associated with neuritic plaques and neurofibrillary tangles, the neuropathologic hallmarks of Alzheimer's disease (AD) 13, 14 . Therefore, both cholinesterases are pharmacologically relevant targets in neurodegenerative disorders, and today's treatment includes cholinesterase inhibitors like donepezil, galantamine, physostigmine, rivastigmine, ect. 15 . Many other compounds acting as inhibitors of cholinesterase are therefore considered as potential AD therapeutics [16] [17] [18] .
Recently we have shown that 4/5-arylethenyloxazoles possess a moderate potency to inhibit AChE and BChE 19 . In this study, we designed new trans-amino-5-arylethenyl-oxazole derivatives where the oxazole molecule has an NH group on one of the substituents. For the synthesis of styryl-oxazoles, the Van Leusen reaction was utilised. Styryl-oxazole that has chlorine as a substituent was then N-alkylated by Buchwald-Hartwig type reaction to give oxazole benzylamines which were tested as cholinesterase inhibitors. All of the styryl-oxazole amines were also photochemically cyclized to give naphthoxazole benzylamines 20 . Naphthoxazoles synthesised by this manner were also tested. This gave a wide range of molecules with either oxazole or the naphthoxazole moiety to evaluate their impact on the cholinesterase inhibitory activity.
Results and discussion

Synthesis and photochemistry of novel oxazole benzylamines
Using the reaction of N-alkylation on the previously synthesised trans-chloro-arylethenyloxazole 1 20 , new trans-amino-5-arylethenyl-oxazole derivatives trans-2-18 were synthesised (Scheme 1) with an aim to add a new functional group at the end of the oxazole derivative that resembles acetylcholine, the substrate of cholinesterase. The Buchwald-Hartwig reaction 21 was utilised with two catalysts and the reaction was optimised for best conditions to enhance the yield. Change of base was crucial for the optimisation of this reaction. Sodium tert-butoxide was previously used as a base but the dehalogenation of the starting material was observed. Caesium carbonate improved yield and conversion. Temperature, solvent and catalyst used were independently varied to give the best conversion. The best conditions found are given in Scheme 1. The catalysed N-alkylation reaction is a complex coupling reaction and it gave a vast array of yields. Some of the substrates were optimised to excellent yields, while in the example of others only moderate to low yields were obtained. There is still some room for optimisation in the future with additional catalysts but at this time this was sufficient.
A vast number of new compounds was synthesised and spectroscopically characterised (See experimental and Supplementary Figures S1-S19). Compounds with a pyridine ring 15 and 16 and that bearing 2-chlorophenyl substituent 13 were synthesised only in trace amounts and these compounds were not further investigated. Pyridine derivatives 15 and 16 could not be obtained probably because of the influence of basicity of the heteroaromatic ring containing nitrogen on the complex reaction steps of Buchwald-Hartwig amination reaction. Only some of the compounds (trans-2, trans-6 and trans-18) were successfully photochemically cyclized into novel polycyclic derivatives 19-21 (Scheme 2). Other starting amines did not react in the electrocyclization reaction and remained unreacted in the reaction solution, some of them as mixture of configurational isomers. The photochemically reactive anilines showed cis-trans photoisomerization during the photoreaction and as the consequence of that gave photocyclization products 19-21 as only cis-configuration is suitable for electrocyclization. Only the cis-isomer of the amine 18 was isolated from the photomixture after the cyclisation reaction, and spectroscopically characterised. It does not mean that the photostationary state is not established in the photomixture in the case of other amines, but without further electrocyclization reaction. During the photocyclization of 2-thienyl (trans-18) derivative, the competitive cleavage of the heteroaromatic moiety occurred resulting in the isolation of the cis-22 and its electrocyclization product 23. The same products were seen also in the 1 H NMR spectrum after photoreaction of trans-17. The difference between these two heteroaromatic amines is that trans-17 does not cyclize to the corresponding electrocyclization product and gave these products only in traces. The formation of the same product 23 can be also explained as the consequence of the cleavage of the heteroaromatic moiety from 21 (Scheme 2) and this pathway of formation of 23 cannot be excluded as both pathways can occur as competitive processes in the same photoreaction.
All compounds were completely spectroscopically characterised. On Figure 1 , UV spectra are given as they are used in the determination of wavelength in cyclisation reactions. Absorption maxima of all of the starting trans-isomers of compounds 2-18 are in the area between 340 nm and 350 nm and that is the reason why irradiation at 350 nm wavelength was used for cyclisation.
All isolated compounds exhibited in the 1 H NMR spectrum a singlet in the range of 7.78-7.81 ppm, which was attributed to the proton on the position 2 of the oxazole ring due to the influence of nitrogen and oxygen found in its immediate vicinity unshaded and shifted to a lower field ( Figure 2 and Supplementary Figures S1-S19). The protons located at position 4 of the oxazole ring showed a singlet in the range of 6.95-6.99 ppm, the ethylenic protons are visible as doublets in the range of 6.99-7.08 ppm with coupling constants between 16 Hz and 17 Hz, characteristic for trans-isomers. For compounds trans-17 and trans-18, the characteristic signals for the furan or thiophene ring are also visible with characteristic coupling constants (See experimental and Supplementary Figure S16 ). In the spectra of electrocyclization products 19-21, two new doublets with cis coupling constants appeared, characteristic for the central ring of the cyclized naphthoxazole. The structure and purity of the synthesised amines were also confirmed by 13 C NMR and two-dimensional NMR techniques as well as HRMS analyses (See experimental and Supplementary Figures S1-S19).
Inhibition of cholinesterases by novel oxazole benzylamines
The eleven new synthetised trans-amino-5-arylethenyl-oxazole derivatives (trans-2-trans-12, and trans-17) were tested in a wide concentration range as BChE inhibitors to evaluate the inhibitor concentration that inhibits 50% of enzyme activity (IC 50 ), presented in Table 1 . The most potent BChE inhibitors were compounds trans-12, trans-10 and trans-8 with an IC 50 of about 30 mM. BChE had the lowest binding affinity for compound trans-11 which was 5.5-fold lower than the most potent inhibitor trans-12. It is interesting to note that the binding affinity of BChE for compounds trans-12, trans-10 and trans-8 was similar as reported for cholinesterase inhibitors BW284C51, huperzine or rivastigmine (IC 50 30 -54 mM) 22 .
Generally, although these compounds, with the exception of compound trans-17, systematically differ only by their substituent on the benzyl group and its substituent position (ortho-, meta-, para-), this structural variation cannot be easily related to IC 50 values. The most potent inhibitors, compounds trans-12, trans-10 and trans-8 have ortho-methoxy, meta-fluoro and meta-methoxy substituents at the phenyl rings, respectively. Moreover, ortho-(trans-12) and meta-(trans-8) analogues had about a 3 times lower IC 50 than their para-methoxy analogue (trans-4). Similarly, the meta-fluoro substituted compound, trans-10, exhibited a 2.5 times lower IC 50 than its para-fluoro analogue, trans-6. In case of the methyl substituent, the position of the substituent was not relevant because all three compounds (trans-3, trans-7 and trans-11) had a similar IC 50 and were the weakest inhibitors among the tested compounds (Table 1) . Nevertheless, the para-substitution and methyl-substitution led to inactive compounds, while the ortho/meta-methoxy and the meta-fluoro were active derivatives. It is not surprising that the activity was noticeably different between the most potent (trans-12) and the weakest inhibitor (trans-11) differed in the methoxy and methyl substituent at position 2, respectively.
Eleven trans-amino-5-arylethenyl-oxazole derivatives inhibited maximally 20% of AChE activity (Supplementary Figure S20 ) and IC 50 values were not determined. Since higher concentrations than 100 mM could not be used due to AChE inhibition by solvent DMSO 23 , the IC 50 values for AChE were presumably much higher than 100 mM.
Four of the polycyclic naphtho[1,2-d]oxazoles compounds (19, 20, 21, 23) and two isolated cis-isomers of amino-5-arylethenyloxazole derivatives (cis-18, cis-22) were also tested as potential inhibitors of cholinesterases. All compounds, except 23, inhibited both enzymes more than 50% with concentrations in mM range and the evaluated IC 50 values are given in Table 1 . The IC 50 for BChE and compound cis-18 was the lowest IC 50 value evaluated in this study. cis-18 was about 5 times more potent inhibitor of BChE than amino-5-arylethenyl-oxazoles trans-12, trans-10 and trans-8 (Table 1) . It is also interesting to note that cis-18 and cis-22 exhibited a higher inhibition effect for BChE than their electrocyclic products 21 and 23, respectively, while polycyclic derivative 20 had about 8-fold higher potency for BChE than its counterpart trans-6 ( Table 1 ).
In the case of AChE, it seems that the electrocyclization and trans-cis isomerisation of amino-5-arylethenyl-oxazole derivatives enabled additional interactions in the active site improving the inhibition potency. The electrocyclization of cis-18 and cis-6 resulted in the thienyl-naphtho [ 
Conclusions
New amino-5-arylethenyl-oxazoles trans-2-18, and cis-18 and cis-22, as well as naphthoxazole benzylamines 19-23 were successfully synthesised using the reaction of N-alkylation on previously synthesised trans-chloro-arylethenyl-oxazole 1. The IC 50 values evaluated for BChE classified the tested compounds as moderate BChE inhibitors. Naphtho[1,2-d]oxazoles showed to be more potent AChE inhibitors than the trans-amino-5-arylethenyl-oxazole 13 C NMR spectra were recorded on a spectrometer at 300 and 600 MHz. All NMR spectra were measured in CDCl 3 using tetramethylsilane as reference. The assignment of signals was based on 2 D-CH correlation and 2 D-HH-COSY experiments. The following abbreviations are used: s, singlet; d, doublet; t, triplet; q, quartette, dd, doublet of doublets; m, multiplet and br, broad. UV spectra were measured on a UV/VIS spectrophotometer. IR spectra were recorded on a FTIR. Mass spectra were obtained on a GC-MS system. Melting points were obtained using a microscope equipped apparatus and are uncorrected. HRMS analyses were carried out on a mass spectrometer. The LC-MS system consisted of an Agilent 1290 LC coupled with an Agilent 6550 iFunnel quadrupole time-of-flight mass spectrometer (Agilent Technologies, Santa Clara, CA, USA). The LC-MS system equipped with a quaternary gradient pump, temperature-controlled column compartment, refrigerated autosampler component, diode array detector (DAD) and MS with electrospray ionisation were used for the identification. Chromatographic separations were performed using Acquity UPLC BEH C18 column, 50 Â 2.1 mm, 1.7 mm (Agilent Technologies, Santa Clara, CA, USA). Gradient elution with mobile phase containing solvent A (0.1% formic acid) and solvent B (acetonitrile) was used. The mobile-phase flow rate was 0.4 mL/ min and the column temperature was maintained at 50 ± 1 C. Substances were analysed in positive electrospray ionisation mode. Nitrogen was a nebuliser and curtain gas. The capillary voltage was 3500 V. Gas temperature was 200 C, gas flow was 14 L/min, nebuliser was 35 psi, sheath gas temperature was 350 C and sheath gas flow was 11 L/min. Data acquisition and processing were performed on a MassHunter Data Acquisition for Q-TOF B.06.01 (B6157) software (Agilent Technologies). Irradiation experiments were performed in a closed quartz vessel in toluene solution in a photochemical reactor equipped with 360 nm lamps. The solvents were removed on the rotatory evaporator under reduced pressure in a ventilated hood.
Synthesis of (E)-5-(4-chlorostyryl)oxazole (trans-1)
Compound trans-1 was synthesised from (E)-3-(4-chlorophenyl)acryladehyde (6.00 mmol, 1 eq) by Van Leusen reaction , 24 with tosylmethylisocyanide (TosMIC) (5.76 mmol, 0.96 eq) reagent and potassium carbonate as base (5.79 mmol, 0.96 eq) in methanol. (E)-5-(4-chlorostyryl)oxazole (trans-1) of compound 17 13 
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